Pyzchiva
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Pyzchiva, covering 2025-11-21 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Pyzchiva (ustekinumab) — Samsung Bioepis NL B.V.
2 regulatory and trial events tracked for Pyzchiva, covering 2025-11-21 to 2026-07-03. Get the full timeline:
Most recent: EMA Authorised: Pyzchiva (ustekinumab) — Samsung Bioepis NL B.V.